Evidence map›Paper›PMID 32507734›Full record

ArticleAnnals of hepatology

Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.

Mauricio Lisker-Melman, Mandana Khalili, Steven H Belle, Norah A Terrault, Hsing-Hua S Lin, Coleman I Smith, Raymond T Chung, Naoky Tsai, Natalie H Bzowej, Tram T Tran and 2 more

Open access · goldAbstract read
In one paragraph

Article in Annals of hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. SSM - population health · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Mauricio Lisker-MelmanWashington University School of Medicine, St. Louis, MO, United States. Electronic address: mlisker@wustl.edu.
Mandana KhaliliUniversity of California San Francisco, San Francisco, CA, United States.
Steven H BelleUniversity of Pittsburgh, Pittsburgh, PA, United States.
Norah A TerraultKeck Medicine at University of Southern California, Los Angeles, CA, United States.
Hsing-Hua S LinUniversity of Pittsburgh, Pittsburgh, PA, United States.
Coleman I SmithGeorgetown University Hospital, Washington, DC, United States.
Raymond T ChungMassachusetts General Hospital, Boston, MA, United States.
Naoky TsaiQueens Medical Center, Honolulu, HI, United States.
Natalie H BzowejOcshner Medical Center, New Orleans, LA, United States.
Tram T TranCedar Sinai Medical Center, Los Angeles, CA, United States.
Sarah Jane SchwarzenbergUniversity of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States.
Hepatitis B Research Network (HBRN)
University of Pittsburgh · USCedars-Sinai Medical Center · USGeorgetown University · USMassachusetts General Hospital · USQueen's Medical Center · USUniversity of California, San Francisco · USUniversity of Minnesota Children's Hospital · USUniversity of Southern California · USWashington University in St. Louis · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Hepatitis B Research Network - Data Coordination CenterU01DK082864 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELLE, STEVEN H. · 2008 to 2019
$25.3M
ZDV VS ZDV + DDL VS ZDV + DDL + NVP IN ASYMPTOMATIC HIV PATIENTSM01RR000040 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 1985 to 2006
$21.1M
Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
Hepatitis B Research Network (HBRN): Natural History and Treatment StudiesU01DK082944 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COOPER, STEWART, KHALILI, MANDANA · 2008 to 2019
$10.0M
Observation Study of Persons with Chronic Hepatitis B Virus infection in North AmericaU01DK082874 · NIDDK · UNIVERSITY HEALTH NETWORK · PI JANSSEN, HARRY · 2008 to 2019
$6.9M
Harvard Hepatitis B ConsortiumU01DK082919 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHUNG, RAYMOND T, LAU, DARYL T · 2008 to 2019
$4.7M
Midwest Hepatitis B ConsortiumU01DK082871 · NIDDK · SAINT LOUIS UNIVERSITY · PI DI BISCEGLIE, ADRIAN MICHAEL · 2008 to 2019
$4.7M
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii ConsortiumU01DK082863 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOK, ANNA S.F. · 2008 to 2020
$3.7M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR000058NCATS NIH HHS UL1 TR001111NCRR NIH HHS M01 RR000040NCRR NIH HHS UL1 RR024986NIAAA NIH HHS K24 AA022523NIDDK NIH HHS P30 DK050306NIDDK NIH HHS U01 DK082843NIDDK NIH HHS U01 DK082863NIDDK NIH HHS U01 DK082864NIDDK NIH HHS U01 DK082866NIDDK NIH HHS U01 DK082867NIDDK NIH HHS U01 DK082871NIDDK NIH HHS U01 DK082872NIDDK NIH HHS U01 DK082874NIDDK NIH HHS U01 DK082919NIDDK NIH HHS U01 DK082923NIDDK NIH HHS U01 DK082927NIDDK NIH HHS U01 DK082943NIDDK NIH HHS U01 DK082944
6 · The paper itself

Abstract

INTRODUCTION AND

objectivesUniversal vaccination at birth and in infancy is key to the elimination of chronic hepatitis B infection. We aimed to assess hepatitis B immune-prophylaxis and perinatal transmission knowledge, in a large and ethnically diverse cohort of previously pregnant North American women, chronically infected with hepatitis B. MATERIALS AND

methodsThe Hepatitis B Research Network (HBRN) is comprised of 28 Clinical Centers in the United States and Canada. Female cohort participants were administered a questionnaire to assess: (1) their assertion of knowledge regarding HBV prophylaxis at birth, testing, and diagnosis of hepatitis B in their children, and (2) the percentage of affirmative to negative responses for each of the HBV-related interventions her child may have received. The relationship between asserted knowledge, actions taken and maternal demographics were assessed.

resultsA total of 351 mothers with 627 children born in or after 1992 were included. Median age at enrollment was 39.8 years. Mothers were mostly foreign-born with the largest percentage from Asia (73.4%) and Africa (11.7%). Of the 627 children, 94.5% had mothers who asserted that they knew whether their child had received HBIG or HBV vaccine at birth, for 88.8% of the children, their mothers indicated that they knew if their child was tested for HBV and for 84.5% of children, their mothers knew if the child was diagnosed with HBV infection. Among children whose mothers asserted knowledge of their HBV management, 95.3% were reported to have received HBIG or HBV vaccine, 83.4% of children were said to have been tested for HBV, and 4.8% of children were said to have been diagnosed with HBV. Younger maternal age was the only factor significantly associated with higher percentage of children for whom mothers reported knowledge of testing (p=0.02) or diagnosis of HBV (p=0.02).

conclusionsWhile high percentages of North American children had mothers asserting knowledge of HBV prophylaxis and testing, knowledge gaps remain, with mothers of 5.5-15.5% of children lacking knowledge of key components of the HBV prevention and diagnosis in the perinatal setting. Targeted education of HBsAg-positive mothers may aid in closing this gap and reducing vertical transmission.

Indexed as

Health Knowledge, Attitudes, PracticePregnancy Complications, InfectiousAdultCanadaFemaleHepatitis B AntibodiesHepatitis B, ChronicHepatitis B VaccinesHumansImmunization, PassiveImmunologic FactorsInfectious Disease Transmission, VerticalPregnancyUnited StatesHepatitis B AntibodiesHepatitis B VaccinesImmunologic FactorsChronic Hepatitis B knowledgeHepatitis B immune-prophylaxisHepatitis B perinatal transmissionHepatitis B preventionHepatitis B transmissionHepatitis B vaccinationHepatitis B vertical transmissionPregnancy

Identifiers

PMID32507734
PMCPMC7738313
OpenAlexW3026309165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.